GameStop stock jumped Friday morning after CEO Ryan Cohen’s buy was disclosed in SEC filings. GME has had a topsy-turvy year. The post GameStop Finds A Bulk Buyer For Its Stock — Its Own CEO appeared first on Investor’s Business Daily.
Adobe stock fell Friday after the digital media and marketing software firm beat fiscal third-quarter estimates but disappointed with its outlook. The post Adobe Stock In Penalty Box As Investors Await New CEO’s Strategy appeared first on Investor’s Business Daily.
Investors looking for new opportunities may find them abroad. Investors poured money into international ETFs this year. The post ETFs Open Up The World To Franklin Templeton Investors appeared first on Investor’s Business Daily.
Everybody on Wall Street knows everything there is to know about popular mega-cap stocks, right? Matt Fruhan, a top fund manager of Fidelity Mega Cap Stock Fund, disagrees. The post How Top Fidelity Manager Beats The Herd With ‘Overanalyzed’ Stocks appeared first on Investor’s Business Daily.
Scott Bessent has had to get used to disapproval from his former Wall Street peers during his time in D.C.—but the Treasury Secretary offered some pointed feedback in an interview at the Republican Party midterm convention last night. Bessent, formerly a partner at Soros Fund Management and the CEO of his own macro hedge fund, […]
At 23, I’ve become a multi-millionaire and built two $20 million dollar companies by refusing to believe in work-life balance. This is the only truth I live by: your 20s are the cheapest years you’ll ever have to buy your 40s. Career advisors, HR departments, and most of the internet will tell a twenty-something to protect their […]
Good morning. Polymarket makes a business out of uncertainty. Now it’s bringing some certainty to its own finances by hiring seasoned CFO Warren Jenson as its first finance chief. Jenson, who has served as CFO of Amazon, Electronic Arts, Delta Air Lines, and NBC (then a General Electric business) as well as Nielsen, will lead […]
Incyte stock is trading just below a buy zone as Big Money gives it the stamp of approval. The post Profitable Biotech Incyte Forms Handle As Institutional Buyers Load Up On Stock appeared first on Investor’s Business Daily.
For about a half-dozen IBD 50 components, the decision on when to sell stocks is at hand. The post When To Sell Stocks: Why Investors May Want To Walk Away From These IBD 50 Stocks appeared first on Investor’s Business Daily.
Marex stock is breaking out past a new buy point and into new highs, as the company’s earnings and sales growth continue to surge. The post Financial Services Leader Marex Breaks Out Past Buy Point And Into New Highs appeared first on Investor’s Business Daily.
